IL49132A - 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them - Google Patents

16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL49132A
IL49132A IL49132A IL4913276A IL49132A IL 49132 A IL49132 A IL 49132A IL 49132 A IL49132 A IL 49132A IL 4913276 A IL4913276 A IL 4913276A IL 49132 A IL49132 A IL 49132A
Authority
IL
Israel
Prior art keywords
androst
disubstituted
ones
preparation
pharmaceutical compositions
Prior art date
Application number
IL49132A
Other versions
IL49132A0 (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Priority to IL58505A priority Critical patent/IL58505A/en
Publication of IL49132A0 publication Critical patent/IL49132A0/en
Publication of IL49132A publication Critical patent/IL49132A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
IL49132A 1975-03-21 1976-03-02 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them IL49132A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL58505A IL58505A (en) 1975-03-21 1976-03-02 16,1l-disubstituted androst-5-ene derivatives and their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11819/75A GB1538227A (en) 1975-03-21 1975-03-21 16,16-disubstituted steroids of the androstene series

Publications (2)

Publication Number Publication Date
IL49132A0 IL49132A0 (en) 1976-05-31
IL49132A true IL49132A (en) 1980-05-30

Family

ID=9993275

Family Applications (2)

Application Number Title Priority Date Filing Date
IL49132A IL49132A (en) 1975-03-21 1976-03-02 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
IL58505A IL58505A0 (en) 1975-03-21 1979-10-19 16,16-disubstituted androst-5-ene derivatives and their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL58505A IL58505A0 (en) 1975-03-21 1979-10-19 16,16-disubstituted androst-5-ene derivatives and their preparation

Country Status (15)

Country Link
JP (2) JPS51118756A (en)
AT (1) AT357700B (en)
AU (1) AU501246B2 (en)
BE (1) BE839751A (en)
CA (1) CA1069498A (en)
CH (2) CH621560A5 (en)
DE (1) DE2610497C2 (en)
DK (1) DK143757C (en)
FR (2) FR2304345A1 (en)
GB (1) GB1538227A (en)
IE (1) IE42308B1 (en)
IL (2) IL49132A (en)
NL (1) NL184111C (en)
SE (2) SE7603410L (en)
ZA (1) ZA761324B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602960A (en) * 1977-05-25 1981-11-18 Beecham Group Ltd Process for preparing 16,16-disubstituted steroids of the androstene series
DE2943778A1 (en) * 1979-10-26 1981-05-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17-Alpha:alkyl-4,15-androstadiene-3-one derivs. - topical antiandrogens effective against acne, seborrhoea, alopecia and hirsutism
DE3514272A1 (en) * 1985-04-17 1986-10-23 Schering AG, 1000 Berlin und 4709 Bergkamen DERMATICA
JPS63300153A (en) * 1987-05-29 1988-12-07 日本碍子株式会社 Building enamel panel
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
JPH06502161A (en) * 1990-10-31 1994-03-10 ビーチャム・グループ・パブリック・リミテッド・カンパニー Topical compositions containing retinoid penetration enhancers
GB9205194D0 (en) * 1992-03-10 1992-04-22 Smithkline Beecham Plc Novel composition
US20050009797A1 (en) * 2001-12-19 2005-01-13 Mitsuaki Nakamura Androstane derivative having substituent in 7- abd 17--positions
CN108558975B (en) * 2018-04-26 2021-03-02 昆明理工大学 12 beta-hydroxy-androstane 4, 14-diene-16-ketone compound and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853926A (en) * 1973-05-29 1974-12-10 Searle & Co 17{62 -hydroxy-16,16-dimethylester-4-en-3-one

Also Published As

Publication number Publication date
CH631996A5 (en) 1982-09-15
CA1069498A (en) 1980-01-08
NL184111B (en) 1988-11-16
DK143757C (en) 1982-03-22
IL49132A0 (en) 1976-05-31
FR2304345A1 (en) 1976-10-15
DE2610497A1 (en) 1976-10-07
BE839751A (en) 1976-09-20
JPS6355488B2 (en) 1988-11-02
ZA761324B (en) 1977-02-23
FR2445340B1 (en) 1983-02-11
JPS61178920A (en) 1986-08-11
JPS51118756A (en) 1976-10-18
SE7603410L (en) 1976-09-22
FR2445340A1 (en) 1980-07-25
ATA191376A (en) 1979-12-15
DK143757B (en) 1981-10-05
IE42308B1 (en) 1980-07-16
DK123476A (en) 1976-09-22
FR2304345B1 (en) 1980-11-07
SE7902256L (en) 1979-03-13
NL7602949A (en) 1976-09-23
IL58505A0 (en) 1980-01-31
AU501246B2 (en) 1979-06-14
AU1220776A (en) 1977-09-22
AT357700B (en) 1980-07-25
NL184111C (en) 1989-04-17
GB1538227A (en) 1979-01-10
DE2610497C2 (en) 1986-10-16
JPS625920B2 (en) 1987-02-07
IE42308L (en) 1976-09-21
CH621560A5 (en) 1981-02-13

Similar Documents

Publication Publication Date Title
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL50815A0 (en) New aminobenzoamides their preparation and pharmaceutical compositions containing them
IL49911A0 (en) New 5-aroylpyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL46959A0 (en) 1,1-diaryl-1-oxadiazolyl-alkylamines,their preparation and pharmaceutical compositions containing them
IL50690A0 (en) Novel benzisothiazole derivatives,their preparation and pharmaceutical compositions containing them
IL50869A (en) Heterocyclylthio-ethylimidazole derivatives,their preparation and pharmaceutical compositions containing them
IL50631A0 (en) 1-benzazolylalkyl-4-substituted-piperidines,their preparation and pharmaceutical compositions containing them
IL49424A0 (en) 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them
IL51309A0 (en) New 1,2-benzisothiazolin-3-ones,their preparation and pharmaceutical compositions containing them
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
IL49280A0 (en) Novel benzophenones,their preparation and pharmaceutical compositions containing them
IL52717A (en) Derivatives of2-phenylamino-imidazoline-(2),their preparation and pharmaceutical compositions containing them
IL50335A (en) Diphenylalkylpolyamine derivatives,their preparation and pharmaceutical compositions containing them
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
IL52137A0 (en) Novel aryltrifluoroethylamines their preparation and pharmaceutical compositions containing them
IL49991A0 (en) L-pyroglutamyl-l-prolinamide,its preparation and pharmaceutical compositions containing it
IL54358A (en) 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides,their preparation and pharmaceutical compositions containing them
IL50156A0 (en) New homophthalimide derivatives,their preparation and pharmaceutical compositions containing them
IL49099A (en) Xanthene-9-carboxylates, their preparation and pharmaceutical compositions containing them
IL50554A (en) 2,9-dioxatricyclodecanes,their preparation and pharmaceutical compositions containing them
IL49319A (en) 4,4-diphenyl-2-hydroxy butylamine derivatives their preparation and pharmaceutical compositions containing them
IL49971A0 (en) New 2-benzoypranone derivatives,their preparation and pharmaceutical compositions containing them
IL51468A0 (en) Novel d-homosteroids their preparation and pharmaceutical compositions containing them
IL46409A (en) 7,8-dihalo-1,2,3,4-tetrahydro-isoquinolines their preparation and pharmaceutical compositions containing them
IL49239A (en) O-aminoethyl methylthiophenyl-ketoximes, their preparation and pharmaceutical compositions containing them